IDSA: Babesiosis

Zusammenfassung

Abstract The purpose of this guideline is to provide evidence-based guidance for the most effective strategies for the diagnosis and management of babesiosis. The diagnosis and treatment of co-infection with babesiosis and Lyme disease will be addressed in a separate Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) guideline [1]. Recommendations for the diagnosis and treatment of human granulocytic anaplasmosis can be

Kerninformationen

e-quality evidence ). Comment: The diagnosis of babesiosis should be based on epidemiological risk factors and clinical evidence, and confirmed by blood smear examination or PCR. II. Can an Active Case of Babesiosis Be Diagnosed Based on a Single Positive Antibody Test or Is a Blood Smear, PCR, or a...

al, or hepatic compromise. Expert consultation with a transfusion services physician or hematologist in conjunction with an infectious diseases specialist is strongly advised. V. How Should Immunocompetent and Immunocompromised Patients Be Monitored After Babesiosis Therapy Is Initiated? How Frequen...

i is endemic in the Northeast and upper Midwest and is the most common cause of human babesiosis ( Figure 3 ) [ 3 , 5 , 17 , 18 ]. Babesiosis due to B. microti imposes a significant health burden in the United States. More than 2000 cases of babesiosis are reported to the CDC annually, but several l...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen